Center Laboratories, Inc. (TPEX:4123)

Taiwan flag Taiwan · Delayed Price · Currency is TWD
38.00
-0.05 (-0.13%)
Jul 16, 2026, 1:30 PM CST
Market Cap28.41B +3.7%
Revenue (ttm)1.60B -1.8%
Net Income10.74B
EPS13.34
Shares Out 746.53M
PE Ratio2.85
Forward PEn/a
Dividend1.75 (4.68%)
Ex-Dividend DateOct 3, 2025
Volume763,606
Open37.90
Previous Close38.05
Day's Range37.90 - 38.20
52-Week Range33.10 - 51.40
Beta0.28
Analystsn/a
Price Targetn/a
Earnings DateAug 13, 2026

About Center Laboratories

Center Laboratories, Inc., a pharmaceutical company, develops, manufactures, and sells pharmaceuticals in Taiwan and internationally. The company offers general medication pharmaceuticals comprising antipyretic analgesics, bronchodilators, anti-inflammatory preparations, antihistamines, expectorants, narcotic antitussives and expectorants, gastrointestinal preparations, non-narcotic antitussives and expectorants, and other medicines. It also provides central nervous system medication consisting of treatments for cerebrovascular disease, dementi... [Read more]

Sector Healthcare
Founded 1959
Country Taiwan
Stock Exchange Taipei Exchange
Ticker Symbol 4123
Full Company Profile

Financial Performance

Financial Statements